Karel Pacák

22.7k total citations · 3 hit papers
205 papers, 11.4k citations indexed

About

Karel Pacák is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Karel Pacák has authored 205 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Surgery, 122 papers in Cancer Research and 106 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Karel Pacák's work include Adrenal and Paraganglionic Tumors (148 papers), Cancer, Hypoxia, and Metabolism (122 papers) and Pituitary Gland Disorders and Treatments (72 papers). Karel Pacák is often cited by papers focused on Adrenal and Paraganglionic Tumors (148 papers), Cancer, Hypoxia, and Metabolism (122 papers) and Pituitary Gland Disorders and Treatments (72 papers). Karel Pacák collaborates with scholars based in United States, France and Germany. Karel Pacák's co-authors include Graeme Eisenhofer, Jacques W.M. Lenders, Massimo Mannelli, David Taïeb, Anne‐Paule Gimenez‐Roqueplo, Mitsuhide Naruse, M. Hassan Murad, Stefan K. Grebe, William F. Young and Quan‐Yang Duh and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Karel Pacák

195 papers receiving 11.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

2014 1.6k citations Graeme Eisenhofer, Karel Pacák et al. The Journal of Clinical Endocrinology & Metabolism profile →
Phaeochromocytoma

2005 1.0k citations Graeme Eisenhofer, Karel Pacák et al. profile →
Personalized Management of Pheochromocytoma and Paraganglioma

2021 200 citations Svenja Nölting, Nicole Bechmann et al. Endocrine Reviews profile →

Peers

Countries citing papers authored by Karel Pacák

Since Specialization

Citations

This map shows the geographic impact of Karel Pacák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Pacák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Pacák more than expected).

Fields of papers citing papers by Karel Pacák

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Pacák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Pacák. The network helps show where Karel Pacák may publish in the future.

Co-authorship network of co-authors of Karel Pacák

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Pacák. A scholar is included among the top collaborators of Karel Pacák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Pacák. Karel Pacák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of succinate dehydrogenase subunit B-deficient tumor models for preclinical immunotherapy testing 2025 ·Cancer Letters ·Katerina Hadrava Vanova, (unknown), Michal Kraus, (unknown), (unknown), (unknown), Timothy J. Garrett, Hans K. Ghayee, Michal Masařík, Herui Wang, Zhengping Zhuang, Jiřı́ Neužil, Chunzhang Yang, Karel Pacák	0
2	Belzutifan for HIF2A-Related Pheochromocytoma and Paraganglioma: A Retrospective Study of Real-World Data 2025 ·Endocrine Practice ·Hussam Alkaissi, (unknown), (unknown), Sriram Gubbi, Alberto S. Pappo, (unknown), John Glod, Zhengping Zhuang, Karel Pacák	0
3	Overview of recent guidelines and consensus statements on initial screening and management of phaeochromocytoma and paraganglioma in SDHx pathogenic variant carriers and patients 2024 ·Best Practice & Research Clinical Endocrinology & Metabolism ·Charlotte Lussey‐Lepoutre, Karel Pacák, Ashley Grossman, David Taïeb, Laurence Amar	7
4	Weakly supervised detection of pheochromocytomas and paragangliomas in CT using noisy data 2024 ·Computerized Medical Imaging and Graphics ·(unknown), (unknown), (unknown), Pritam Mukherjee, Jianfei Liu, Abhishek Jha, Mayank Patel, Karel Pacák, Ronald M. Summers	0
5	Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms 2023 ·Frontiers in Oncology ·(unknown), Barry L. Shulkin, Abhishek Jha, Karel Pacák, David Taïeb	1
6	Preclinical Models of Neuroendocrine Neoplasia 2022 ·Cancers ·(unknown), (unknown), Suresh Kumar, Po Hien Ear, Kate E Lines, Nitin Roper, Karel Pacák, Emily K. Bergsland, Dawn E. Quelle, James R. Howe, Yves Pommier, Jaydira Del Rivero	6
7	Personalized Management of Pheochromocytoma and Paraganglioma breakdown → 2021 ·Endocrine Reviews ·Svenja Nölting, Nicole Bechmann, David Taïeb, Felix Beuschlein, Martin Faßnacht, Matthias Kroiß, Graeme Eisenhofer, Ashley Grossman, Karel Pacák	200
8	Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid 2020 ·Clinical Cancer Research ·Yang Liu, Ying Pang, (unknown), (unknown), Veronika Caisová, (unknown), David Taïeb, Katerina Hadrava Vanova, Hans K. Ghayee, Jiřı́ Neužil, Mark Levine, Chunzhang Yang, Karel Pacák	35
9	Genetic Determinants of Pheochromocytoma and Paraganglioma Imaging Phenotypes 2020 ·Journal of Nuclear Medicine ·David Taïeb, Karel Pacák	7
10	Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies 2018 ·PLoS ONE ·Dominique Barbolosi, Joakim Crona, (unknown), Karel Pacák, David Taïeb	4
11	Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging 2018 ·Frontiers in Endocrinology ·Rami Alrezk, (unknown), Isabel Tena, Karel Pacák	67
12	HIF-2alpha: Achilles' heel of pseudohypoxic subtype paraganglioma and other related conditions 2017 ·European Journal of Cancer ·Sri Harsha Tella, David Taïeb, Karel Pacák	16
13	Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB -Associated Metastatic Pheochromocytoma and Paraganglioma 2015 ·Clinical Cancer Research ·Ingo Janssen, Elise M. Blanchet, Karen T. Adams, Clara C. Chen, Corina Millo, Peter Herscovitch, David Taïeb, Electron Kebebew, Hendrik Lehnert, Antonio Tito Fojo, Karel Pacák	180
14	Prospective Study of ⁶⁸ Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites 2015 ·Journal of Clinical Oncology ·Samira M. Sadowski, Vladimir Neychev, Corina Millo, Joanna H. Shih, Naris Nilubol, Peter Herscovitch, Karel Pacák, Stephen J. Marx, Electron Kebebew	254
15	Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH? 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Paraskevi Xekouki, Karel Pacák, Madson Q. Almeida, Christopher A. Wassif, Pierre Rustin, Maria Nesterova, Maria De La Luz Sierra, (unknown), Evan Ball, Monalisa Ferreira Azevedo, (unknown), Charalampos Lyssikatos, Martha Quezado, Nicholas J. Patronas, Barbara Ferrando, Barbara Pasini, Aristides Lytras, G. Tolis, Constantine A. Stratakis	113
16	False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease 2011 ·Endocrine Related Cancer ·(unknown), (unknown), Clara C. Chen, James C. Reynolds, Millie Whatley, Alexander Ling, Leilani B Mercado-Asis, Karen T. Adams, Victoria Martucci, Tito Fojo, Karel Pacák	88
17	Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas 2011 ·Surgery ·Aradhana M. Venkatesan, Hari Trivedi, Karen T. Adams, Electron Kebebew, Karel Pacák, Marybeth S. Hughes	15
18	Functional Imaging ofSDHx-Related Head and Neck Paragangliomas: Comparison of¹⁸F-Fluorodihydroxyphenylalanine,¹⁸F-Fluorodopamine,¹⁸F-Fluoro-2-Deoxy-d-Glucose PET,¹²³I-Metaiodobenzylguanidine Scintigraphy, and¹¹¹In-Pentetreotide Scintigraphy 2011 ·The Journal of Clinical Endocrinology & Metabolism ·Kathryn S. King, Clara C. Chen, Dimitrios Alexopoulos, Millie Whatley, James C. Reynolds, Nicholas J. Patronas, Alexander Ling, Karen T. Adams, Paraskevi Xekouki, Howard M. Lando, Constantine A. Stratakis, Karel Pacák	99
19	Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in the Succinate Dehydrogenase Subunit B Gene 2008 ·The Journal of Clinical Endocrinology & Metabolism ·Henri Timmers, Karel Pacák, Thanh Huynh, Mones Abu‐Asab, Maria Tsokos, Maria J. Merino, Bora E. Baysal, Karen T. Adams, Graeme Eisenhofer	89
20	Stress : basic mechanisms and clinical implications 1995 ·New York Academy of Sciences eBooks ·George P. Chrousos, Richard McCarty, Karel Pacák, Giovanni Cizza, Esther Sternberg, Philip W. Gold, Richard Květňanský	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact